Heparins are sulphated glycosaminoglycans that inactivate thrombin, factor Xa, and several other coagulation factors; act by enhancing activity of the plasma coagulation inhibitor, antithrombin III (AT III); and prolong the activated partial thromboplastin time (APTT). The anti-Xa assay is the preferred method for monitoring low-molecular-weight heparin (LMWH) therapy because of reduced sensitivity of APTT. Heparin is absent in normal plasma. The heparin level obtained has to be analyzed taking into account the treatment given to the patient (type of heparin, dosage, administration mode, time of sampling, etc) and the desired therapeutic effect. It is clinically recommended that platelet counts be monitored frequently in patients receiving unfractionated heparin (UFH) or LMWH in order to detect heparin-induced thrombocytopenia (HIT).
No special preparation is needed for Factor Xa Heparin. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing Factor Xa Heparin. Your doctor depending on your condition will give specific instructions.
|UNISEX||All age groups||0.30 - 0.70IU/ml|
|UNISEX||All age groups||0.50 - 1.00 IU/ml|